Perpetual LTD Astrazeneca PLC Transaction History

Perpetual LTD

$8.06 Trillion
Q3 2025

A detailed history of Perpetual LTD transactions in Astrazeneca PLC stock. As of the latest transaction made, Perpetual LTD holds 14,119 shares of AZN stock, worth $1.26 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,119

Previous 17,946 21.33%

Holding current value

$1.26 Million

Previous $1.25 Billion 13.62%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 10, 2025	SELL	$68.72 - $82.11 $262,991 - $314,234	-3,827 Reduced 21.33%	14,119 $1.08 Billion
Q2 2025 Jul 11, 2025	SELL	$64.87 - $75.0 $377,608 - $436,575	-5,821 Reduced 24.49%	17,946 $1.25 Billion
Q1 2025 Apr 24, 2025	SELL	$65.37 - $77.96 $33,142 - $39,525	-507 Reduced 2.09%	23,767 $1.75 Billion
Q4 2024 Jan 17, 2025	SELL	$63.2 - $79.58 $1.23 Million - $1.55 Million	-19,416 Reduced 44.44%	24,274 $1.59 Billion
Q3 2024 Oct 09, 2024	SELL	$76.67 - $87.62 $538,376 - $615,267	-7,022 Reduced 13.85%	43,690 $3.4 Billion

Q2 2024 Jul 30, 2024	BUY	$66.81 - $80.83 $232,431 - $281,207	3,479 Added 7.37%	50,712 $3.96 Billion
Q1 2024 Apr 09, 2024	BUY	$61.03 - $69.57 $378,080 - $430,986	6,195 Added 15.1%	47,233 $3.22 Billion
Q4 2023 Feb 15, 2024	SELL	$61.89 - $69.28 $38,619 - $43,230	-624 Reduced 1.5%	41,038 $2.76 Billion
Q3 2023 Oct 10, 2023	SELL	$64.85 - $71.7 $217,442 - $240,410	-3,353 Reduced 7.45%	41,662 $2.82 Billion
Q2 2023 Jul 13, 2023	SELL	$69.91 - $75.81 $7,410 - $8,035	-106 Reduced 0.23%	45,015 $3.22 Billion
Q1 2023 May 08, 2023	BUY	$63.15 - $71.6 $2.65 Million - $3.01 Million	41,988 Added 1340.19%	45,121 $3.13 Billion
Q3 2020 Dec 08, 2020	BUY	$53.07 - $61.1 $166,268 - $191,426	3,133 New	3,133 $172,000

Others Institutions Holding AZN

# of Institutions

1,498

Shares Held

500M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perpetual LTD, based on Form 13F filings with the SEC.

News

Stay updated on Perpetual LTD with notifications on news.

Account